About us
A spin-out from Oxford University, Oxford BioSignals Ltd was formed in 2000 in order to develop a range of monitoring algorithms across a variety of applications. In 2009, the industrial arm of the business that arose from the broader implementation of the technology was sold to Rolls Royce.
In the same year, the company merged with t+ Medical Ltd and to strengthen the technical capabilities and focus on the development and expansion of their medical device products and services. As a result of the merger, the company was renamed OBS Medical Ltd.
Commitment to Quality
We are a world leader in innovative software solutions for the improvement of patients’ lives in the hospital, at home and through industry with advanced clinical solutions for new drug development. This is achieved through our commitment to Quality in all areas of our business and is supported with certification approval for ISO13485:2003 and ISO9001:2008 from the LRQA.